The internationalisation of innovation to China: the case of AstraZeneca PLC
Zhao, Shasha ORCID: https://orcid.org/0000-0001-8993-4915, Tan, Hui, Papanastassiou, Marina and Harzing, Anne-Wil
ORCID: https://orcid.org/0000-0003-1509-3003
(2016)
The internationalisation of innovation to China: the case of AstraZeneca PLC.
Academy of International Business Annual Conference Proceedings.
In: Academy of International Business Annual Meeting, 27-30 June 2016, New Orleans.
.
ISSN 2078-4430
[Conference or Workshop Item]
|
PDF
- Final accepted version (with author's formatting)
Download (474kB) | Preview |
Abstract
The internationalisation of firms is increasingly concerned with locating innovation activities in the most appropriate locations, particularly for more strategic research and development projects. This article attempts to explore this area by taking a slightly different perspective – the internationalisation of innovations by advance-economy firms in less-advanced economies – which is increasingly prominent in international business development. This article describes the history of international expansion of AstraZeneca from 1990s to year 2014, which demonstrates the development of the company with its unique approach to international business operations, and in particular its innovation. In order to explain such a progress, considerations are given to a number of theoretical frameworks in terms of their explanatory power.
Item Type: | Conference or Workshop Item (Paper) |
---|---|
Research Areas: | A. > Business School > International Management and Innovation > International Business group |
Item ID: | 17052 |
Notes on copyright: | © The Author(s). Reproduced with permission of Academy of International Business |
Useful Links: | |
Depositing User: | Shasha Zhao |
Date Deposited: | 23 Jun 2015 10:00 |
Last Modified: | 29 Nov 2022 21:52 |
URI: | https://eprints.mdx.ac.uk/id/eprint/17052 |
Actions (login required)
![]() |
View Item |
Statistics
Additional statistics are available via IRStats2.